Flu virus researcher commended by Vic Premier
A medical researcher, Dr Michelle Tate, has received $8000 and a commendation in recognition of her investigation into the ‘flu virus’ from the Premier of Victoria. The recognition of her work, welcomed by international scientists, was part of presentations made at Government House for the 2011 Premier’s Award for Health and Medical Research.
The Chelsea resident focused her postgraduate studies on the relationship between the body’s immune system and the ‘flu virus’.
Central to her study was trying to work out why the virus affected different people in different ways.
Each year the influenza A virus causes worldwide illness and death. People are seldom reinfected by the same type of influenza because of the ability of the virus to mutate and escape recognition by the body’s immune system.
As Dr Tate says, this is one reason why vaccination is sometimes ineffective.
During her investigations, she characterised the body’s first-line defences against influenza virus infection. Dr Tate also identified structures on the surface of influenza virus that were recognised by these defences and showed that virus mutants that escaped detection were able to cause severe disease.
Scientists worldwide who are working to understand the public health threat of drift and shift strains of influenza have welcomed the breakthrough.
The findings provide a more detailed understanding of the immune defences involved in the early recognition and destruction of influenza and other viruses.
They are also an important step in facilitating the development of new antiviral medications.
During the course of her PhD, Dr Tate authored 10 papers in international peer-reviewed journals including the Journal of Virology and the Journal of Immunology.
She undertook her PhD in the Department of Microbiology and Immunology, the University of Melbourne. She is now working at the Monash Institute of Medical Research.
Vaxxas to advance its microarray patches for COVID vaccination
Vaxxas will receive AU$3.2m from BARDA to accelerate work advancing its high-density microarray...
Global competition targets 'undruggable' cancer protein
A new global competition offering over US$500,000 in prizes aims to spur drug discovery...
SMi Systems appoints Dr Ankur Mutreja as Senior Advisor
Mutreja was previously Head of Global South Partnerships at CEPI, where he was responsible for...